Drug Trial Radar · NCT06892639
Evaluation of D-Fi for the Treatment of Wounds Due to DEB
Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Mar 27, 2025
Primary completion
Sep 2027
Study completion Feb 2042
Sponsor
- Lead sponsor
- Castle Creek Biosciences, LLC.Industry
- Sponsor type
- Industry
- Collaborators
- Prosoft Clinical
- First posted
- Mar 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether administration of D-Fi in addition to standard of care improves wound healing as compared to standard of care alone (control) in children, adolescents, and adults with Dystrophic Epidermolysis Bullosa.
Conditions
- Dystrophic Epidermolysis Bullosa
Interventions
D-FiBiological
D-Fi is composed of fibroblasts isolated from the subject's skin biopsies which are genetically corrected with the full length COL7A1 gene encoding for type VII collagen.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The difference in Complete (100%) Wound Closure of the Target Wound Pair at either Week 22 (Visit 6), and Week 24 (Visit 7) or at Week 24 (Visit 7) and Week 26 (Visit 8) as assessed by a Blinded Assessor.Time frame: Week 26
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Stanford University School of Medicine, Dermatology
Redwood City, California
Mission Dermatology
Santa Margarita, California
Children's Hospital Colorado
Aurora, Colorado
University of Massachusetts
Worcester, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.